Connection
Divij Mathew to Janus Kinase Inhibitors
This is a "connection" page, showing publications Divij Mathew has written about Janus Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.826 |
|
|
|
-
Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, Ngiow SF, Klapholz M, Jun S, Zhang Z, Zorc R, Davis CW, Diehn M, Giles JR, Huang AC, Hwang WT, Zhang NR, Schoenfeld AJ, Carpenter EL, Langer CJ, Wherry EJ, Minn AJ. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science. 2024 06 21; 384(6702):eadf1329.
Score: 0.826